Short answer · Medically reviewed summary · Last updated: 2026-05-08
The primary ICD-10 code for malignant neoplasm of the bladder is C67, while the corresponding ICD-9 code is 188. These codes are used globally for clinical documentation, insurance billing, and tracking the prevalence of bladder cancer in healthcare systems. How are ICD codes used for bladder cancer? ICD (International Classification of Diseases) codes are essential for standardizing the medical reporting of bladder cancer.
ICD10 code of Bladder Cancer and ICD9 code
ICD-10 and ICD-9 codes for Bladder Cancer, with classification details for clinicians, coders and patients.
The primary ICD-10 code for malignant neoplasm of the bladder is C67, while the corresponding ICD-9 code is 188. These codes are used globally for clinical documentation, insurance billing, and tracking the prevalence of bladder cancer in healthcare systems.
How are ICD codes used for bladder cancer?
ICD (International Classification of Diseases) codes are essential for standardizing the medical reporting of bladder cancer. The ICD-10 code C67 is further sub-classified based on the specific anatomical site of the malignancy within the bladder, such as the trigone (C67.0) or the lateral wall (C67.2). These codes allow researchers and clinicians to track bladder cancer outcomes accurately across different populations.
What factors influence the diagnosis of bladder cancer?
Diagnosis typically involves clinical evaluation followed by diagnostic procedures to confirm the presence of bladder cancer. Physicians often utilize a combination of the following to determine the extent of the disease:
- Cystoscopy: Direct visualization of the bladder lining.
- Biopsy: Transurethral resection of bladder tumor (TURBT) to obtain tissue for pathology.
- Imaging: CT urography or MRI to assess for muscle invasion or metastasis.
- Urine Cytology: Microscopic examination of cells shed in the urine.
Is there support for those living with bladder cancer?
Navigating a diagnosis of bladder cancer can be emotionally taxing, but you are not alone. Currently, 68 people with bladder cancer have joined the DiseaseMaps.org community to share their personal experiences and coping strategies. Connecting with others who understand the unique challenges of bladder cancer treatment can provide significant emotional support and practical insights into managing symptoms and recovery.
Next steps
- Consult with a urologic oncologist to discuss staging and personalized treatment plans for bladder cancer.
- Join the DiseaseMaps community to connect with other patients and caregivers.
- Review resources from the Bladder Cancer Advocacy Network (BCAN) for the latest patient-centered information.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.
References
- World Health Organization (WHO) - ICD-10 Version: 2019
- National Cancer Institute (NCI) - Bladder Cancer PDQ®
- Bladder Cancer Advocacy Network (BCAN)
- NIH Genetic and Rare Diseases Information Center (GARD)
